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 BACKGROUND 
 Sickle cell anaemia (SCA) is an autosomal recessive heredi-
tary haemoglobinopathy. About 5% of the world’s popula-
tion carries the gene, and each year about 300 000 infants 
are born with major haemoglobin disorders. 1 The public 
health implications of SCA are clear as it causes either 
death or disability. The predominant symptom associated 
with SCA is pain resulting from the occlusion of small 
blood vessels by abnormally ‘sickle-shaped’ red blood cells 
(RBCs). 
 Priapism is a SCA complication which has a great 
impact on boys’ sexual health. Adolescents with priapism 
frequently fail to seek medical assistance due to embar-
rassment and the lack of understanding of the relation-
ship between painful sustained erections and SCA. Early 
recognition of the different clinical types of priapism and 
appropriate management can prevent irreversible fi brosis 
and impotency. 
 Poor healing of leg ulcers is also a well-described com-
plication of SCA and represents a disabling and chronic 
repercussion associated with a more severe clinical course. 
Cholelithiasis and retinopathy are also SCA related compli-
cations. Managing adolescents with SCA requires a multi-
disciplinary approach in a fi eld where treatment options 
are frequently controversial. 
 CASE PRESENTATION 
 A 14-year-old boy from Angola with SCA presented with 
a 1 year history of a recalcitrant leg wound. The wound 
was the result of a blow from an iron rod. The patient had 
undergone a split-thickness skin graft in Angola. As it had 
been unsuccessful, his parents decided to bring him to 
Portugal. He was fi rst diagnosed with SCA at the age of 5 
and had approximately three sickle cell pain crises per year 
but he had never been previously followed-up in a sickle-
cell clinic. Since the traumatic event he had had limited 
mobility and had not been attending school. 
 On examination, there was an 11 cm by 7 cm wound 
above the left medial malleolus. The wound tissue was 
>60% thick yellow slough and <40% granulation with 
copious serous secretions. General examination was oth-
erwise unremarkable except for mild icteric sclerae and a 
grade 2/6 ejection systolic murmur at the left sternal edge. 
He was Tanner stage 4 and had a body mass index of 
16 kg/m 2 . 
 Further evaluation elicited a 1 month history of wak-
ing with painful erections persisting for up to 4 h and that 
resolved spontaneously. He was not aware of the link 
between these symptoms and SCA. A multi-disciplinary 
approach was used to manage his SCA with non-healing 
traumatic leg ulcer and stuttering priapism. 
 INVESTIGATIONS 
 He had a low haemoglobin of 6.9 g/dl with a reticulocyte 
count of 322 000 (11.5%) and a haematocrit of 20%; a high 
white cell count of 18×10 9 /l with a polymorph cell count 
of 8×10 9 /l (54%); and a high platelet count of 535×10 9 /l. 
 Urine and complete biochemical investigations were 
all normal with a ferritin level of 143.7 ng/ml; except for 
a high lactate dehydrogenase (LDH) of 2408 U/l (normal 
range from 208–378 U/l). Blood cultures were sterile. Chest 
radiography was normal. At room air, the patient’s oxygen 
saturation was 95% at rest. 
 High-performance liquid chromatography confi rmed 
homozygous SCA (HbSS) with a quantitative analysis of 
73% of HbS and a low HbF of 1.7%. Ultrasonography 
revealed an atrophic 6 cm spleen and multiple gall-
stones. Ophthalmologist examination fi ndings were 
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compatible with a non-proliferative retinopathy of SCA . 
Echocardiography, pulmonary function study and tran-
scranial doppler ultrasonography were all normal. 
 TREATMENT 
 Early intervention regarding the non-healing leg ulcer was 
bed rest, 16 days of intravenous antibiotics and analgesia. 
Ulcer management consisted of selective debridement of 
necrotic tissue and application of an enzymatic debrider 
covered with fat gauze to prevent adherence of secondary 
dressing to the wound bed. At the end of the 2nd week of 
admission he had a split-thickness skin graft. 
 With respect to the priapism a two-phased management 
approach was implemented. The fi rst consisted of instruc-
tions to drink plenty of liquids, urinate, take a warm bath, 
undertake physical activity and ask for analgesics. If it did 
not resolve spontaneously after 3 to 4 h, urgent urological 
opinion should be sorted. 
 The second phase of management for priapism started 
as an outpatient. He underwent a simple RBC transfusion 
programme consisting of one transfusion every 4 weeks for 
8 months. The transfused erythrocytes were leukoreduced 
and matched the patient for the C, E and K1 antigens. This 
was also to improve the healing after the split-thickness 
skin grafts. 
 Concerning the clinically silent gallstones a conservative 
management plan was adopted. No therapy for the non-
proliferative retinopathy was indicated. 
 OUTCOME AND FOLLOW-UP 
 The fi rst month of management of the leg ulcer, with the 
skin graft was performed as an inpatient. All other man-
agement was done as an outpatient with the follow-up of 
a multi-disciplinary team. 
 In the beginning of the erythrocyte transfusion pro-
gramme all his episodes of priapism were stuttering, 
occurring twice to three times a week and lasting up to 4 
h before spontaneously resolving. After the fourth transfu-
sion he started to experience less frequent episodes with 
shorter durations but it was not until the seventh trans-
fusion that he reported having no more episodes of pria-
pism. Initially his HbS was high at 73% and the reduction 
to 30% recommended was only achieved after the fourth 
transfusion. His haemoglobin concentration reached a 
steady state around 9 mg/dl. 
 No complication associated to the blood transfusion was 
observed. Iron stores were fully monitored and at the end 
of the 8th month transfusion programme ferritin levels did 
not reach the maximum of 1000 ng/ml. 
 He is still priapism free on his 4th month of follow-up 
after the last transfusion. 
 Regarding his leg ulcer, after the graft an initial improve-
ment and a faster healing were observed around the fourth 
erythrocyte transfusion. Meanwhile, in the last 2 months 
recurrence of the ulcer was noticed despite adequate care 
and follow-up by the plastic surgical team. Another split-
thickness skin graft is being taken into consideration. 
 Since his fi rst admission he has already had a total of 
14 months of monthly follow-up and the long-term goals 
of full closure of the wound and return to school have not 
yet been observed although successful management of 
the recurrent priapism was achieved. For the non-prolif-
erative rethinopathy he will have an annual dilated eye 
examination carried out by an ophthalmologist experi-
enced in retinal disease. 
 DISCUSSION 
 It has been 100 years since Herrick published the fi rst 
medical case report of sickle cell disease (SCD). However, 
its management and complications are still controversial 
now. 
 Although some evidence supports the use of blood 
transfusion and hydroxycarbamide, to date, no drugs have 
been developed that specifi cally target the pathophysiol-
ogy of this disease. 2 
 The term SCD is used to refer to all the different gen-
otypes that cause the characteristic clinical syndrome, 
whereas SCA, the most common form of SCD, refers spe-
cifi cally to homozygosity for the S allele. 
 Homozygous HbSS have the most severe phenotype 
and can progress with different clinical severity and 
complications. 
 SCD is a single amino acid molecular disorder of hae-
moglobin leading to its pathological polymerisation. The 
clinical manifestations are driven by two major patho-
physiological processes: vaso-occlusion with ischaemia-
reperfusion injury and haemolytic anaemia. 
 Deoxygenation causes HbS to polymerise, leading to 
sickled erythrocytes. Vaso-occlusion results from the inter-
action of sickled erythrocytes with leucocytes and the vas-
cular endothelium. Vaso-occlusion then leads to infarction, 
haemolysis and infl ammation; infl ammation enhances the 
expression of adhesion molecules, further increasing the 
tendency of sickled erythrocytes to adhere to the vascular 
endothelium and to worsen vaso-occlusion. 2 This vaso-
occlusive-viscosity is responsible for complications of dis-
ease like acute painful episodes, osteonecrosis of bone and 
the acute chest syndrome. 3 
 Reperfusion of the ischaemic tissue generates free radi-
cals and oxidative damage. The damaged erythrocytes 
release free haemoglobin into the plasma, which strongly 
bind to nitric oxide, causing functional nitric oxide defi -
ciency and contributing to the development of vascu-
lopathy. 2 This reduction in levels of nitric oxide alters the 
balance between vasoconstriction and vasodilation skew-
ing it towards vasoconstriction. Pulmonary hypertension, 
priapism, leg ulceration and stroke, are all SCA complica-
tions that can be linked to the intensity of haemolysis. 3 
 Adolescents are at special risk as they can suffer from 
all the SCA complications either those related to the vaso-
occlusive viscosity phenomena as well as those related to 
haemolysis. 4  5 
 In our adolescent we can associate the multiple-disease 
related complications with some risk factors such as: a low 
HbF and high platelet count are associated with priapism. 
Being a male (3:1) and also the lower haemoglobin concen-
tration and lower HbF levels are risk factors for the non-
healing leg ulcer. The rate of intravascular haemolysis with 
permanent high LDH is a risk factor to the cholelithiasis. 4 
 The maintenance of high fetal haemoglobin concentra-
tions beyond infancy has long been recognised to amelio-
rate many aspects of SCD including predicting increased 
life expectancy and reducing the frequency of both acute 
pain and leg ulcers. 6  7 The fetal haemoglobin concentration 
in patients with SCA varies from 1% to 30%, and is inher-
ited as a quantitative genetic trait. 2 In our case we consider 
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that a fetal haemoglobin concentration of only 1.7% is our 
adolescent’s main risk factor. 
 Chronic leg ulcers have been reported to occur in 25% 
to 70% of adolescent and adult sickle cell patients, depend-
ing on the geographic area evaluated and sickle genotype. 4 
The events surrounding the initial skin ulceration in SCA 
suggest two different causes: traumatic or spontaneous. In 
the traumatic form, there is a clear history of trauma, even 
involving minor trauma such as insect bites. Those arising 
spontaneously are believed to represent skin infarction. 
 Recently, vasculopathic abnormalities and intensity of 
haemolysis have been recognised as a pathway to end 
organ damage and complications such as leg ulceration; 
promoting the non-healing of wounds, especially those in 
lower extremities. 5  8  9 
 Leg ulcers are often associated with a more severe clini-
cal course. Despite the fact that this complication has been 
recognised since the early times of SCA, there has been 
little improvement in the effi cacy of its management and 
clinical outcome over the past 100 years. 8 The treatment of 
leg ulceration is still unsatisfactory and information from 
controlled clinical trials is sparse. Prevention of trauma is 
the cornerstone for eviction of chronic leg ulcers in SCA 
patients. 4  8 
 Chronic recalcitrant ulcers are a challenge and tech-
niques include debridement and scrupulous hygiene; 
iodosorb wound dressing to induce localised proinfl amma-
tory cytokines such as tumour necrosis factor and inter-
leukin-6; low-pressure elastic bandage and above-the-knee 
elastic stockings to improve venous circulation and split-
thickness skin grafts can be successful strategies for treat-
ing leg ulcers. 10 There is also some evidence for the use of 
oral administration of zinc sulfate (220 mg three times a 
day) to promote healing of leg ulcers although we did not 
use it. 10 The role for regular, long-term blood transfusions 
in leg ulcers is controversial but some authors do indicate 
them if ulcers persist despite optimal care. 2  10 
 In the case presented, despite all the efforts to achieve a 
complete long-term healing of the leg ulcer a relapse was 
observed in the fi rst 10 months after split-thickness skin 
graft and blood transfusion programme. Our outcome did 
not come as a surprise as recurrence rates within 2 years, 
even in successfully grafted and healed ulcers, are docu-
mented in literature to be as high as in 80–97% in patients 
with SCA. 4 
 Historically, priapism was thought to be present in 5% 
to 10% of patients with SCA. A survey was conducted in 
1999 to investigate the prevalence of priapism in patients 
with SCA aged 5 to 20 years. Of the 98 patients surveyed, 
approximately 27% reported having at least one episode 
of priapism. The probability of having at least one episode 
of priapism by age 20 was reported to be 89%. Patients 
had the average age of 12 when they had their fi rst epi-
sode, and the majority of episodes were nocturnal. 11 
 There are three kinds of priapism: stuttering priapism 
(recurrent ischaemic priapism), ischaemic priapism (veno-
occlusive, low fl ow) and non-ischaemic priapism (arterial, 
high fl ow). 12 
 Ischaemic priapism and stuttering priapism are pheno-
typic manifestations of SCA. 
 Stuttering priapism is an uncommon recurrent form of 
ischaemic priapism consisting of episodes of unwanted, 
painful erections that typically last for <3 h. It occurs 
repeatedly with intervening periods of detumescence. If 
these episodes are not treated, it may evolve into a classic 
ischaemic priapism and eventually lead to irreversible cor-
poral fi brosis with permanent erectile dysfunction. 13 
 The current molecular hypothesis for stuttering pria-
pism in SCA proposes that insuffi cient basal levels of phos-
phodiesterase type-5 are available in the corpora to degrade 
cyclic guanosine monophosphate (cGMP). Nocturnal erec-
tions result from normal neuronal production and surges 
of cGMP. In the context of SCA stuttering priapism, these 
nocturnal surges in cGMP go unchecked, resulting in stut-
tering priapism. 12 
 The goals of managing stuttering ischaemic priapism 
are: prevention of future episodes, preservation of erectile 
function and balancing the risks versus benefi ts of various 
treatment options. 
 There are no defi nitive guidelines available for the treat-
ment of SCA-related priapism. The evidence consists pri-
marily of case reports, a few small trials and prospective 
protocols. For the treatment of paediatric acute priapism, 
conservative measures are initially prudent, but they 
should not interfere with decisions to proceed to the next 
level of treatment. For the fi rst 2 h, patients at home should 
be encouraged to drink extra fl uids, urinate, exercise and 
take oral analgesics if needed. 12 – 16 These simple steps 
have occasionally been suffi cient enough to produce detu-
mescence. If the priapism continues beyond 2 h, patients 
should report to the emergency department for further 
assessment. 14  16 For the next 2 to 4 h, patients should be 
given intravenous hydration and analgesics, since this 
often suffi ciently resolves the episode. Anxiolytics, such 
as lorazepam or midazolam, and supplemental oxygen 
may also be given if needed. If priapism persists beyond 
4 h, intracavernosal aspiration of blood and instillation of 
an α-agonist should be performed under local or regional 
anaesthesia. 12  13 Phenylephrine and epinephrine appear to 
be equally safe and effi cacious for use in dilute solutions. 
There is also a new emerging use of phosphodiesterase-5 
inhibitors and fi nasteride with success. 15 Aspiration and 
irrigation may be repeated as necessary and initial manage-
ment with intravenous hydration, analgesics, anxiolytics 
and oxygen should be continued. If the erection contin-
ues beyond approximately 12 h, shunt placement should 
be considered. 13  16 This should be the last option, since 
rates of impotence are higher, and most paediatric patients 
respond well to pharmacologic treatments. 
 Long-term erythrocyte transfusion has an established 
role in the management of both acute and chronic com-
plications in SCD but its role in priapism is controver-
sial. 2  16 In our case we thought it would be an advantage 
as transfusion corrects anaemia, decreases the percentage 
of HbS, suppresses HbS synthesis and reduces haemo-
lysis, all of which are of potential benefi t for managing 
complications. 
 Stuttering priapism of our adolescent case-report showed 
resolution after the fourth transfusion and he is priapism 
free since the seventh transfusion so benefi ts were observed 
with the long-term blood transfusion programme. 
 The key message is that boys with SCA should be 
alerted regarding the need to seek prompt specialised treat-
ment for any episode of priapism that lasts longer than 2 
h. Eighty six per cent of patients with SCA do not sponta-
neously report complaints regarding intermittent priapism 
BMJ Case Reports 2012; doi:10.1136/bcr.11.2011.51464 of 5
during regular consultations because of cultural factors, 
absence of perception of the phenomenon as abnormal 
especially in children and adolescents, shame or a lack of 
understanding of the relationship of the phenomenon to 
SCA. 14 The physician must actively inquire about priapism 
in the anamnesis of any patient with SCA. 
 Children with SCA have an increased risk of develop-
ing pigment gallstones that initially may be asympto-
matic. Their complications are diffi cult to distinguish from 
vaso-occlusive abdominal pain and they can sometimes 
threaten the patient’s life. The literature is inconsistent in 
relation to the best approach to silent gallstones. 17 – 19 Some 
recommend an elective laparoscopic cholecystectomy pro-
cedure for paediatric patients with SCA to prevent the risk 
of requiring an emergency cholecystectomy however, our 
experience together with literature data support an expect-
ant management of clinically silent gallstones in SCA with 
good outcomes. 17  19 
 Sickle retinopathy is common in all forms of SCA and 
can be of a non-proliferative or a proliferative form. Non-
proliferative retinopathy is an occlusion of small blood 
vessels of the eye and retinal neovascularisation is very 
common (30% as young as 5–7 years of age) and is usu-
ally not associated with defects in visual acuity. 10  20 Some 
authors recommend treatment with hydroxyurea as it may 
slow or prevent further vaso-occlusion and have a favour-
able effect by reducing subsequent neovascularisation. 10 
 However, taking into consideration that there is no 
risk of visual acuity defi ciency and that hydroxyurea is 
also related to worsen the course of leg ulcers, the use of 
hydroxyurea was not recommended in our patient. 19 
 One can not underestimate the substantial impairment 
of quality of life in adolescents with SCA. In our patient 
since his traumatic event in Angola 2 years ago his life suf-
fered a complete downturn with school deprivation and 
emigration in order to look for better healthcare. 
 Defi nitely further multicentre randomised clinical tri-
als are required to evaluate the effi cacy of different treat-
ment options and to defi ne safe and effective management 
strategies for multiple SCA related complications in 
adolescents. 
 Learning points 
 ▶  Young people, especially boys from certain ethnic 
cultures, do not disclose their sexual problems (such 
as priapism) unless they are asked in a non-judgmental 
environment. 
 The fi rst approach to stuttering priapism is to  ▶
encourage the patients to drink extra fl uids, urinate, 
exercise and take oral analgesics if needed. 
 If the priapism continues beyond 2 h, patients should  ▶
report to the emergency department for further 
assessment. 
 Prevention of leg ulcers in patients with SCA is better  ▶
than trying to treat them after they have arisen. 
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